Krystal Biotech Inc.
Organization details
- Legal name
- Krystal Biotech Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters city
- Pittsburgh
- Headquarters state / province
- Pennsylvania
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- KRYS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001711279
- EIN
- 82-1080209
Board of directors
-
Catherine Mazzacco · DirectorSince 2023
-
Christopher Mason · DirectorSince 2023
-
Daniel Janney · DirectorSince 2023
-
Dino A. Rossi · DirectorSince 2023
-
Everett Rand Sutherland · DirectorSince 2023
-
Julian S. Gangolli · DirectorSince 2023
-
Krish S. Krishnan · Director · President and CEOSince 2023
-
Suma Krishnan · Director · President, R&DSince 2023
Chief executives
Director election results
Annual meeting of May 19, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
82.8%
-
97.4%
-
97.4%
Board connections
3 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Outlook Therapeutics Inc. Same sectorvia Julian S. Gangolli
-
Sight Sciences Inc. Same sectorvia Catherine Mazzacco
-
Upstream Bio Inc. Same sectorvia Everett Rand Sutherland
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $105,273,821
- 142 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −520 | $354.54 | $184,361 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −520 | $354.54 | $184,361 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −2,029 | $355.57 | $721,452 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −2,006 | $355.57 | $713,273 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −3,297 | $356.37 | $1,174,952 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −3,267 | $356.37 | $1,164,261 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −3,981 | $357.57 | $1,423,486 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −3,962 | $357.57 | $1,416,692 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −3,143 | $358.42 | $1,126,514 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −3,180 | $358.42 | $1,139,776 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −3,357 | $359.39 | $1,206,472 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −3,392 | $359.39 | $1,219,051 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −2,266 | $360.46 | $816,802 |
| Sep 4, 2026 | Suma Krishnan Director, Officer (President, R&D), 10% owner | Open-market sale | −2,320 | $360.47 | $836,290 |
| Sep 4, 2026 | Krish S. Krishnan Director, Officer (President and CEO), 10% owner | Open-market sale | −1,214 | $361.61 | $438,995 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Krystal Biotech Inc.
Who is the CEO of Krystal Biotech Inc.?
Krish S. Krishnan is Krystal Biotech Inc.'s President and CEO.
How many directors are on Krystal Biotech Inc.'s board?
Krystal Biotech Inc.'s board has 8 directors: Catherine Mazzacco, Christopher Mason, Daniel Janney, Dino A. Rossi, Everett Rand Sutherland, Julian S. Gangolli, Krish S. Krishnan and Suma Krishnan.
Are Krystal Biotech Inc. insiders buying or selling shares?
Over the last 12 months, Krystal Biotech Inc. insiders made no open-market purchases and sold $105.3 million of shares in 142 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="krystal-biotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.